was evaluated using a commercial two-stage kit, Biophen Anti-Xa (221005).
Protein copolymers of different concentrations were first lyophilized
and redissolved in plasma. Dissolved compounds were then added to
the heparin solution in 150 mM NaCl (0.1 mg mL–1), giving a final heparin concentration of 0.045 IU mL–1 (12.5 nM) and protein copolymer/heparin mass ratio from 0 to 150
for all protein copolymers. Kit reagents were utilized according to
the manufacturer’s instructions. To run the calorimetric assay,
40 μL of the protein copolymer–heparin solution was added
to a 96-well microplate followed by the addition of 40 μL of
antithrombin and incubation for 2 min. Then, 40 μL of factor
Xa was added and incubated for another 2 min. Afterward, 40 μL
of the factor-Xa-specific chromogenic substrate was added to the solution
and left to react for 2 min. Finally, the reaction was quenched by
introducing 80 μL of 2% citric acid. The absorbance at 405 nm
was recorded immediately using a BioTek Cytation three-microplate
reader. The anticoagulant activity is inversely proportional to the
measured absorption intensity, and the percentage of neutralization
was determined using a calibration curve constructed according to
the manufacturer’s instructions (